Clinical Trial Update: Evaluation of 3APS in Patients With Mild to Moderate Alzheimer's Disease [Phase 3]

View source ↗

Summary

This document provides an update on a Phase 3 clinical trial evaluating 3APS in patients with mild to moderate Alzheimer's disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• 3APS

Snippet

Sponsor: Bellus Health Inc. - a GSK company | Conditions: Alzheimer Disease | Phase 3 | Status: UNKNOWN